Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solu-Medrol in total knee-arthroplasty
NCT02332616Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in osteoarthritis (OA), sponsored by Rigshospitalet. Started Jan 2015; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02332616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332616.